Compare REX AI Equity Premium Income ETF (AIPI) vs Amphastar Pharmaceuticals Inc (AMPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
REX AI Equity Premium Income ETF vs Amphastar Pharmaceuticals Inc — how do they compare? REX AI Equity Premium Income ETF trades at $37.66, while Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M). The key difference: REX AI Equity Premium Income ETF is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AIPI | AMPH | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $44.93 | $30.81 |
52-Week Low | $32.45 | $16.87 |
Market Cap | — | $868.62M |
Enterprise Value | — | $1.27B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About REX AI Equity Premium Income ETF
AIPI provides exposure to leading artificial intelligence firms while seeking to generate monthly income. It uses a covered call strategy to capture premiums from the volatility of AI-related stocks.
Read more on AIPI →About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →
